SUN PHARMACEUTICALS LTD Planned brands: Noveltreat (for chronic weight management) Sematrinity (for Type-2 diabetes) Regulatory clearance has already been granted by Indias drug regulator ahead of launch
GLP-1 medications may activate key biological pathways that support longevity. Taking smaller (micro) doses may lower the risk of side effects, creating harmony with your bodys natural processes to support healthspan
References Paternoster S, Falasca M
This glucagon-like peptide-1 (GLP-1) receptor agonist encourages insulin secretion from the pancreas, slows gastric emptying, and reduces appetite, resulting in higher energy expenditure and lower food consumption
Product Properties Lyophilized powder
Semaglutide treatment is suitable for a wide range of individuals, particularly those who are struggling with metabolic conditions or weight management